Kamala Harris is not offering sweeping change, even as voters express dissatisfaction about the direction of the country. She’s an institutionalist who wants to preserve democratic ideals, and ...
Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.